Aminopyrrolic Synthetic Receptors for Monosaccharides: A Class of Carbohydrate‐Binding Agents Endowed with Antibiotic Activity versus Pathogenic YeastsCristina Nativi, Stefano Roelens, Oscar Francesconi et al.|Chemistry - A European Journal|2012Cited by 35
Treatment sequence with either irinotecan/cetuximab followed by FOLFOX-4 or the reverse strategy in metastatic colorectal cancer patients progressing after first-line FOLFIRI/bevacizumab: An Italian Group for the Study of Gastrointestinal Cancer phase III, randomised trial comparing two sequences of therapy in colorectal metastatic patientsStefano Cascinu, Rossana Berardi, Francesco Leone et al.|European Journal of Cancer|2017Cited by 30
Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE StudyStefania Gori, Fabrizio Nicolis, Alessandra Fabi et al.|Cancers|2023Cited by 9